GLOBAL HEREDITARY OROTIC ACIDURIA MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Market News

Recent Developments

• In October 2023, the University of Oxford and Harrington Discovery Institute at University Hospitals in Cleveland, Ohio launch  the Oxford-Harrington Rare Disease Centre Therapeutics Accelerator with an official signing event at the University of Oxford. The event was hosted by the Oxford-Harrington Rare Disease Centre (OHC), a partnership established in 2019 between the University of Oxford and Harrington Discovery Institute. Attendance at the signing included leaders from OHC, the University of Oxford, the Harrington family, University Hospitals, and Oxford Science Enterprises.

Partnerships

• In January 2022, Pfizer Inc., a pharmaceutical company and Beam, a pharmaceutical company, entered into an exclusive multi-target research collaboration to advance novel in vivo base editing programs for a range of rare diseases.